Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

RxSight, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

NEW YORK, AUG. 13, 2025 (GLOBE NEWSWIRE) -- WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLP ANNOUNCES THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN FILEDON BEHALF OF ALL PERSONS OR ENTITIES WHO PURCHASED THE SECURITIES OF RXSIGHT, INC. (NASDAQ: RXST) (RXSIGHT OR THE COMPANY).

SHAREHOLDERS WHO LOST MONEY ON THEIR RXSIGHT, INC. (NASDAQ: RXST) INVESTMENT SHOULD CONTACT WOLF HALDENSTEIN IMMEDIATELY AS THE LEAD PLAINTIFF DEADLINE IS SEPTEMBER 22ND

NEW YORK, AUG. 13, 2025 (GLOBE NEWSWIRE) -- LEADING SECURITIES LAW FIRM BLEICHMAR FONTI & AULD LLP ANNOUNCES THAT A LAWSUIT HAS BEEN FILED AGAINST RXSIGHT, INC. (NASDAQ: RXST) AND CERTAIN OF THE COMPANY'S SENIOR EXECUTIVES FOR POTENTIAL VIOLATIONS OF THE FEDERAL SECURITIES LAWS. IF YOU INVESTED IN RXSIGHT, YOU ARE ENCOURAGED TO OBTAIN ADDITIONAL INFORMATION BY VISITING: HTTPS://WWW.BFALAW.COM/CASES-INVESTIGATIONS/RXSIGHT-INC-CLASS-ACTION-LAWSUIT.

RXSIGHT STOCK: LOSE MONEY ON YOUR RXSIGHT, INC. (NASDAQ:RXST) INVESTMENT? CONTACT BFA LAW BEFORE THE SEPTEMBER 22 LEGAL DEADLINE

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN RXSIGHT TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS

SHAREHOLDER ACTION REMINDER: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF RXSIGHT

NEW YORK , AUG. 12, 2025 /PRNEWSWIRE/ -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN RXSIGHT, INC. ("RXSIGHT, INC." OR THE "COMPANY") (NASDAQ: RXST) OF A CLASS ACTION SECURITIES LAWSUIT. CLASS DEFINITION: THE LAWSUIT SEEKS TO RECOVER LOSSES ON BEHALF OF RXSIGHT, INC. INVESTORS WHO WERE ADVERSELY AFFECTED BY ALLEGED SECURITIES FRAUD BETWEEN NOVEMBER 7, 2024 AND JULY 8, 2025.

RXSIGHT, INC. SUED FOR SECURITIES LAW VIOLATIONS - INVESTORS SHOULD CONTACT LEVI & KORSINSKY FOR MORE INFORMATION - RXST

NEW YORK , AUG. 11, 2025 /PRNEWSWIRE/ -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OFRXSIGHT, INC. (NASDAQ: RXST). SHAREHOLDERS WHO PURCHASED SHARES OF RXST DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENT.

RXSIGHT, INC. SUED FOR SECURITIES LAW VIOLATIONS - INVESTORS SHOULD CONTACT THE GROSS LAW FIRM BEFORE SEPTEMBER 22, 2025 TO DISCUSS YOUR RIGHTS - RXST

NEW YORK, AUG. 11, 2025 (GLOBE NEWSWIRE) -- LEADING SECURITIES LAW FIRM BLEICHMAR FONTI & AULD LLP ANNOUNCES THAT A LAWSUIT HAS BEEN FILED AGAINST RXSIGHT, INC. (NASDAQ: RXST) AND CERTAIN OF THE COMPANY'S SENIOR EXECUTIVES FOR POTENTIAL VIOLATIONS OF THE FEDERAL SECURITIES LAWS. IF YOU INVESTED IN RXSIGHT, YOU ARE ENCOURAGED TO OBTAIN ADDITIONAL INFORMATION BY VISITING: HTTPS://WWW.BFALAW.COM/CASES-INVESTIGATIONS/RXSIGHT-INC-CLASS-ACTION-LAWSUIT.

RXST COURT NOTICE: RXSIGHT, INC. INVESTORS MAY HAVE BEEN AFFECTED BY FRAUD -- CONTACT BFA LAW BEFORE SEPTEMBER 22 IF YOU SUFFERED LOSSES (NASDAQ:RXST)

NEW YORK , AUG. 11, 2025 /PRNEWSWIRE/ -- WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLP ANNOUNCES THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN FILEDON BEHALF OF ALL PERSONS OR ENTITIES WHO PURCHASED THE SECURITIES OF RXSIGHT, INC. (NASDAQ: RXST) ("RXSIGHT" OR THE "COMPANY"). PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION RXSIGHT, INC. CLASS ACTION LAWSUIT SUMMARY DEFENDANT: RXSIGHT, INC. (NASDAQ: RXST) CLASS PERIOD: INVESTORS WHO PURCHASED OR OTHERWISE ACQUIRED RXSIGHT SECURITIES WITHIN THE RELEVANT PERIOD OF NOVEMBER 7, 2024 THROUGH JULY 8, 2025, INCLUSIVE, MAY BE ELIGIBLE.

LOS ANGELES , AUG. 11, 2025 /PRNEWSWIRE/ --THE DJS LAW GROUPANNOUNCES THAT IT IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OFRXSIGHT, INC. ("RXSIGHT" OR "THE COMPANY") (NASDAQ: RXST) FOR VIOLATIONS OF THE SECURITIES LAWS. INVESTIGATION DETAILS: THE INVESTIGATION FOCUSES ON WHETHER THE COMPANY ISSUED MISLEADING STATEMENTS AND/OR FAILED TO DISCLOSE INFORMATION PERTINENT TO INVESTORS.

RXSIGHT, INC. INVESTIGATED FOR SECURITIES FRAUD VIOLATIONS - CONTACT THE DJS LAW GROUP TO DISCUSS YOUR RIGHTS - RXST

NEW YORK, AUG. 07, 2025 (GLOBE NEWSWIRE) -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF RXSIGHT, INC. (NASDAQ: RXST).

INVESTORS IN RXSIGHT, INC. SHOULD CONTACT THE GROSS LAW FIRM BEFORE SEPTEMBER 22, 2025 TO DISCUSS YOUR RIGHTS  RXST

ALISO VIEJO, CALIF., AUG. 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RXSIGHT, INC., AN OPHTHALMIC MEDICAL DEVICE COMPANY DEDICATED TO PROVIDING HIGH-QUALITY CUSTOMIZED VISION TO PATIENTS FOLLOWING CATARACT SURGERY, TODAY REPORTED FINANCIAL RESULTS FOR THE THREE MONTHS ENDED JUNE 30, 2025.

RXSIGHT, INC. REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

NEW YORK , AUG. 7, 2025 /PRNEWSWIRE/ -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF RXSIGHT, INC. (NASDAQ: RXST). SHAREHOLDERS WHO PURCHASED SHARES OF RXST DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENT.

RXSIGHT, INC. SUED FOR SECURITIES LAW VIOLATIONS - INVESTORS SHOULD CONTACT THE GROSS LAW FIRM FOR MORE INFORMATION - RXST

LOS ANGELES , AUG. 5, 2025 /PRNEWSWIRE/ --THE DJS LAW GROUPANNOUNCES THAT IT IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OFRXSIGHT, INC. ("RXSIGHT" OR "THE COMPANY") (NASDAQ: RXST) FOR VIOLATIONS OF THE SECURITIES LAWS. INVESTIGATION DETAILS: THE INVESTIGATION FOCUSES ON WHETHER THE COMPANY ISSUED MISLEADING STATEMENTS AND/OR FAILED TO DISCLOSE INFORMATION PERTINENT TO INVESTORS.

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES EXCEEDING $75,000 IN RXSIGHT TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS

DEADLINE ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF RXSIGHT

NEW YORK , AUG. 4, 2025 /PRNEWSWIRE/ -- WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLPANNOUNCES THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN FILEDON BEHALF OF ALL PERSONS OR ENTITIES WHO PURCHASED THE SECURITIES OF RXSIGHT, INC. (NASDAQ: RXST) ("RXSIGHT" OR THE "COMPANY"). PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION RXSIGHT, INC. CLASS ACTION LAWSUIT SUMMARY DEFENDANT:RXSIGHT, INC. (NASDAQ: RXST) CLASS PERIOD: INVESTORS WHO PURCHASED OR OTHERWISE ACQUIRED RXSIGHT SECURITIES WITHIN THE RELEVANT PERIOD OF NOVEMBER 7, 2024 THROUGH JULY 8, 2025, INCLUSIVE, MAY BE ELIGIBLE.

NEW YORK, AUG. 04, 2025 (GLOBE NEWSWIRE) -- WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLP ANNOUNCES THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN FILEDON BEHALF OF ALL PERSONS OR ENTITIES WHO PURCHASED THE SECURITIES OF RXSIGHT, INC. (NASDAQ: RXST) (RXSIGHT OR THE COMPANY).

PHILADELPHIA , AUG. 4, 2025 /PRNEWSWIRE/ -- BERGER MONTAGUE PC , A NATIONALLY RECOGNIZED SECURITIES LITIGATION LAW FIRM, IS INVESTIGATING POTENTIAL SECURITIES LAW VIOLATIONS INVOLVING RXSIGHT, INC. ("RXSIGHT" OR THE "COMPANY") (NASDAQ: RXST). A CLASS ACTION LAWSUIT WAS RECENTLY FILED ON BEHALF OF INVESTORS WHO ACQUIRED RXSIGHT SECURITIES BETWEEN NOVEMBER 7, 2024 AND JULY 8, 2025 (THE "CLASS PERIOD").

RXST INVESTOR ALERT: BERGER MONTAGUE ADVISES RXSIGHT (NASDAQ: RXST) INVESTORS OF A SEPTEMBER 22, 2025 DEADLINE

ALISO VIEJO, CALIF., AUG. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RXSIGHT, INC., AN OPHTHALMIC MEDICAL DEVICE COMPANY DEDICATED TO PROVIDING HIGH-QUALITY CUSTOMIZED VISION TO PATIENTS FOLLOWING CATARACT SURGERY, TODAY ANNOUNCED THE APPOINTMENT OF RAYMOND W. COHEN TO ITS BOARD OF DIRECTORS.

RXSIGHT, INC. APPOINTS RAYMOND W. COHEN TO ITS BOARD OF DIRECTORS

NEW YORK , AUG. 1, 2025 /PRNEWSWIRE/ -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN RXSIGHT, INC. ("RXSIGHT, INC." OR THE "COMPANY") (NASDAQ: RXST) OF A CLASS ACTION SECURITIES LAWSUIT. CLASS DEFINITION: THE LAWSUIT SEEKS TO RECOVER LOSSES ON BEHALF OF RXSIGHT, INC. INVESTORS WHO WERE ADVERSELY AFFECTED BY ALLEGED SECURITIES FRAUD BETWEEN NOVEMBER 7, 2024 AND JULY 8, 2025.

RXSIGHT, INC. SUED FOR SECURITIES LAW VIOLATIONS - CONTACT LEVI & KORSINSKY BEFORE SEPTEMBER 22, 2025 TO DISCUSS YOUR RIGHTS - RXST

NEW YORK, JULY 31, 2025 (GLOBE NEWSWIRE) -- WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLP ANNOUNCES THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN FILEDON BEHALF OF ALL PERSONS OR ENTITIES WHO PURCHASED THE SECURITIES OF RXSIGHT, INC. (NASDAQ: RXST) (RXSIGHT OR THE COMPANY).

NEW YORK , JULY 31, 2025 /PRNEWSWIRE/ -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OFRXSIGHT, INC. (NASDAQ: RXST). SHAREHOLDERS WHO PURCHASED SHARES OF RXST DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENT.

INVESTORS IN RXSIGHT, INC. SHOULD CONTACT THE GROSS LAW FIRM BEFORE SEPTEMBER 22, 2025 TO DISCUSS YOUR RIGHTS - RXST

LOS ANGELES , JULY 31, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUPANNOUNCES THAT IT IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OFRXSIGHT, INC. ("RXSIGHT" OR "THE COMPANY") (NASDAQ: RXST) FOR VIOLATIONS OF THE SECURITIES LAWS. INVESTIGATION DETAILS: THE INVESTIGATION FOCUSES ON WHETHER THE COMPANY ISSUED MISLEADING STATEMENTS AND/OR FAILED TO DISCLOSE INFORMATION PERTINENT TO INVESTORS.

NEW YORK, JULY 30, 2025 (GLOBE NEWSWIRE) -- LEADING SECURITIES LAW FIRM BLEICHMAR FONTI & AULD LLP ANNOUNCES THAT A LAWSUIT HAS BEEN FILED AGAINST RXSIGHT, INC. (NASDAQ: RXST) AND CERTAIN OF THE COMPANY'S SENIOR EXECUTIVES FOR POTENTIAL VIOLATIONS OF THE FEDERAL SECURITIES LAWS. IF YOU INVESTED IN RXSIGHT, YOU ARE ENCOURAGED TO OBTAIN ADDITIONAL INFORMATION BY VISITING: HTTPS://WWW.BFALAW.COM/CASES-INVESTIGATIONS/RXSIGHT-INC-CLASS-ACTION-LAWSUIT.

RXST INVESTORS: RXSIGHT, INC. (NASDAQ:RXST) INVESTORS MAY HAVE BEEN AFFECTED BY FRAUD  CONTACT BFA LAW BY SEPTEMBER 22 ABOUT POTENTIALLY RECOVERING LOSSES

FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES EXCEEDING $75,000 IN RXSIGHT TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU SUFFERED LOSSES EXCEEDING $75,000 IN RXSIGHT BETWEEN NOVEMBER 7, 2024 AND JULY 8, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK , JULY 29, 2025 /PRNEWSWIRE/ -- FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST RXSIGHT, INC. ("RXSIGHT" OR THE "COMPANY") (NASDAQ: RXST) AND REMINDS INVESTORS OF THE SEPTEMBER 22, 2025 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.

LOS ANGELES , JULY 28, 2025 /PRNEWSWIRE/ --THE DJS LAW GROUPANNOUNCES THAT IT IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OFRXSIGHT, INC. ("RXSIGHT" OR "THE COMPANY") (NASDAQ: RXST) FOR VIOLATIONS OF THE SECURITIES LAWS. INVESTIGATION DETAILS: THE INVESTIGATION FOCUSES ON WHETHER THE COMPANY ISSUED MISLEADING STATEMENTS AND/OR FAILED TO DISCLOSE INFORMATION PERTINENT TO INVESTORS.

PHILADELPHIA , JULY 25, 2025 /PRNEWSWIRE/ -- BERGER MONTAGUE PC , A NATIONAL SECURITIES LITIGATION LAW FIRM ANNOUNCES IT IS INVESTIGATING POTENTIAL SECURITIES FRAUD CLAIMS INVOLVING RXSIGHT, INC. ("RXSIGHT" OR THE "COMPANY") (NASDAQ: RXST), FOLLOWING THE RECENT FILING OF A FEDERAL SECURITIES CLASS ACTION LAWSUIT. THE LAWSUIT ALLEGES THAT DEFENDANTS FAILED TO DISCLOSE TO INVESTORS THAT: (1) RXSIGHT WAS EXPERIENCING "ADOPTION CHALLENGES" AND/OR STRUCTURAL ISSUES RESULTING IN DECLINES IN SALES AND UTILIZATION; (2) DEFENDANTS HAD OVERSTATED THE DEMAND FOR RXSIGHT'S PRODUCTS; AND (3) AS A RESULT, RXSIGHT WAS UNLIKELY TO MEET ITS OWN PREVIOUSLY ISSUED FINANCIAL GUIDANCE FOR FISCAL YEAR 2025.

BERGER MONTAGUE PC INVESTIGATES SECURITIES CLAIMS AGAINST RXSIGHT, INC. (NASDAQ: RXST)

NEW YORK--(BUSINESS WIRE)---- $RXST #CLASSACTION--FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST RXSIGHT, INC. (RXSIGHT OR THE COMPANY) (NASDAQ: RXST) AND REMINDS INVESTORS OF THE SEPTEMBER 22, 2025 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY. FARUQI & FARUQI IS A LEADING NATIONAL SECURITIES LAW FIRM WITH OFFICES IN NEW YORK, PENNSYLVANIA, CALIFORNIA AND GEORGIA. THE FIRM H.

LOS ANGELES , JULY 25, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUPANNOUNCES THAT IT IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OFRXSIGHT, INC. ("RXSIGHT" OR "THE COMPANY") (NASDAQ: RXST) FOR VIOLATIONS OF THE SECURITIES LAWS. INVESTIGATION DETAILS: THE INVESTIGATION FOCUSES ON WHETHER THE COMPANY ISSUED MISLEADING STATEMENTS AND/OR FAILED TO DISCLOSE INFORMATION PERTINENT TO INVESTORS.

INVESTORS CAN CONTACT THE LAW FIRM AT NO COST TO LEARN MORE ABOUT RECOVERING THEIR LOSSES 

RXSIGHT, INC. INVESTORS: COMPANY INVESTIGATED BY THE PORTNOY LAW FIRM

NEW YORK--(BUSINESS WIRE)--ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES THAT A SHAREHOLDER FILED A CLASS ACTION ON BEHALF OF PURCHASERS OF SECURITIES OF RXSIGHT, INC. (NASDAQ: RXST) BETWEEN NOVEMBER 7, 2024 AND JULY 8, 2025. RXSIGHT DESCRIBES ITSELF AS A COMMERCIAL-STAGE MEDICAL TECHNOLOGY COMPANY, ENGAGED IN THE RESEARCH AND DEVELOPMENT, MANUFACTURE, AND SALE OF LIGHT ADJUSTABLE INTRAOCULAR LENSES. FOR MORE INFORMATION, SUBMIT A FORM, EMAIL ATTORNEY PHILLIP KIM, OR GIVE US A.

ROSEN LAW FIRM URGES RXSIGHT, INC. (NASDAQ: RXST) STOCKHOLDERS WITH LOSSES IN EXCESS OF $100K TO CONTACT THE FIRM FOR INFORMATION ABOUT THEIR RIGHTS

NEW YORK, JULY 23, 2025 (GLOBE NEWSWIRE) -- BERNSTEIN LIEBHARD LLP ANNOUNCES THAT A SHAREHOLDER HAS FILED A SECURITIES CLASS ACTION LAWSUIT ON BEHALF OF INVESTORS (THE CLASS) WHO PURCHASED OR ACQUIRED THE SECURITIES OF RXSIGHT, INC. (RXSIGHT OR THE COMPANY) (NASDAQ: RXST) BETWEEN NOVEMBER 7 , 202 4 AND JU LY 8 , 202 5, INCLUSIVE. FOR MORE INFORMATION, SUBMIT A FORM AT RXSIGHT, INC. SHAREHOLDER CLASS ACTION LAWSUIT, EMAIL INVESTOR RELATIONS MANAGER PETER ALLOCCO AT PALLOCCO@BERNLIEB.COM, OR CALL US AT (212) 951-2030.

RXSIGHT, INC. (NASDAQ: RXST) INVESTOR ALERT INVESTORS WITH LARGE LOSSES IN RXSIGHT INC. SHOULD CONTACT BERNSTEIN LIEBHARD LLP TO DISCUSS THEIR RIGHTS

NEW YORK, JULY 23, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF (RXSIGHT OR THE COMPANY) (NASDAQ: RXST). SUCH INVESTORS ARE ADVISED TO CONTACT DANIELLE PEYTON AT NEWACTION@POMLAW.COM OR 646-581-9980, EXT.7980.

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMSON BEHALF OF INVESTORS OF RXSIGHT, INC. - RXST

NEW YORK , JULY 22, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF ("RXSIGHT" OR THE "COMPANY") (NASDAQ: RXST). SUCH INVESTORS ARE ADVISED TO CONTACT DANIELLE PEYTON AT NEWACTION@POMLAW.COM OR 646-581-9980, EXT.

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF RXSIGHT, INC. - RXST

NEW YORK, JULY 22, 2025 (GLOBE NEWSWIRE) -- LEADING SECURITIES LAW FIRM BLEICHMAR FONTI & AULD LLP ANNOUNCES AN INVESTIGATION INTO RXSIGHT, INC. (NASDAQ: RXST) FOR POTENTIAL VIOLATIONS OF THE FEDERAL SECURITIES LAWS. IF YOU INVESTED IN RXSIGHT, YOU ARE ENCOURAGED TO OBTAIN ADDITIONAL INFORMATION BY VISITING: HTTPS://WWW.BFALAW.COM/CASES-INVESTIGATIONS/RXSIGHT-INC-CLASS-ACTION-LAWSUIT.

RXST LOSS ALERT: LOSE MONEY ON RXSIGHT, INC. (NASDAQ: RXST)? YOU MAY HAVE BEEN AFFECTED BY FRAUD AND ARE URGED TO CONTACT BFA LAW

LOS ANGELES--(BUSINESS WIRE)---- $RXST--RXSIGHT, INC. INVESTIGATED FOR SECURITIES FRAUD VIOLATIONS - CONTACT THE DJS LAW GROUP TO DISCUSS YOUR RIGHTS  RXST.

RXSIGHT, INC. INVESTIGATED FOR SECURITIES FRAUD VIOLATIONS - CONTACT THE DJS LAW GROUP TO DISCUSS YOUR RIGHTS  RXST

NEW YORK , JULY 17, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF ("RXSIGHT" OR THE "COMPANY") (NASDAQ: RXST). SUCH INVESTORS ARE ADVISED TO CONTACT DANIELLE PEYTON ATNEWACTION@POMLAW.COMOR 646-581-9980, EXT.

ALISO VIEJO, CALIF., JULY 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST)  RXSIGHT, INC., AN OPHTHALMIC MEDICAL DEVICE COMPANY DEDICATED TO PROVIDING HIGH-QUALITY CUSTOMIZED VISION TO PATIENTS FOLLOWING CATARACT SURGERY, TODAY ANNOUNCED SELECT PRELIMINARY FINANCIAL RESULTS FOR THE SECOND QUARTER 2025 AND REVISED FULL-YEAR 2025 GUIDANCE. THE COMPANY WILL HOST A CONFERENCE CALL ON TUESDAY, JULY 8, 2025, AT 5:00 P.M. EASTERN TIME.

RxSight, Inc.

RXST

Price

Financials Overview

Financial Reports

No items found.

Press Releases

RxSight, Inc.

RXST.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

RXST